scholarly article | Q13442814 |
P50 | author | Lisa H Tostanoski | Q59427648 |
P2093 | author name string | Ming Guo | |
Peipei Zhang | |||
Christopher M Jewell | |||
Walter Royal | |||
James I Andorko | |||
Yu-Chieh Chiu | |||
Xiangbin Zeng | |||
P2860 | cites work | An Immunomodulatory GpG Oligonucleotide for the Treatment of Autoimmunity via the Innate and Adaptive Immune Systems | Q44625295 |
Surface-engineered polyelectrolyte multilayer capsules: synthetic vaccines mimicking microbial structure and function | Q49030612 | ||
Nanoporous polyelectrolyte vaccine microcarriers. A formulation platform for enhancing humoral and cellular immune responses | Q49054872 | ||
Polyelectrolyte microcapsules as antigen delivery vehicles to dendritic cells: uptake, processing, and cross-presentation of encapsulated antigens | Q49123460 | ||
Mechanically tunable, self-adjuvanting nanoengineered polypeptide particles. | Q51005289 | ||
Novel Hollow Polymer Shells by Colloid-Templated Assembly of Polyelectrolytes. | Q52803764 | ||
CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. | Q53015646 | ||
A Suppressive Oligodeoxynucleotide Enhances the Efficacy of Myelin Cocktail/IL-4-Tolerizing DNA Vaccination and Treats Autoimmune Disease | Q61853102 | ||
Polyelectrolyte Multilayers Assembled Entirely from Immune Signals on Gold Nanoparticle Templates Promote Antigen-Specific T Cell Response | Q85278186 | ||
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
Laminins affect T cell trafficking and allograft fate | Q30577194 | ||
Matrix polyelectrolyte microcapsules: new system for macromolecule encapsulation. | Q31170009 | ||
Protein encapsulation via porous CaCO3 microparticles templating | Q33206684 | ||
Plasmacytoid dendritic cells in multiple sclerosis: chemokine and chemokine receptor modulation by interferon-beta | Q34117705 | ||
Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis | Q34312767 | ||
Interferon‐β inhibits toll‐like receptor 9 processing in multiple sclerosis | Q34680345 | ||
Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells | Q34947419 | ||
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance | Q34985424 | ||
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis | Q36094091 | ||
Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation | Q36167500 | ||
Modular Vaccine Design Using Carrier-Free Capsules Assembled from Polyionic Immune Signals. | Q36376261 | ||
Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy | Q36398777 | ||
Engineering antigens for in situ erythrocyte binding induces T-cell deletion | Q36512070 | ||
Antigen kinetics determines immune reactivity | Q36516144 | ||
Intrinsic immunogenicity of rapidly-degradable polymers evolves during degradation | Q36581724 | ||
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis | Q36661068 | ||
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome | Q37070610 | ||
Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis | Q37679881 | ||
Spray-assisted polyelectrolyte multilayer buildup: from step-by-step to single-step polyelectrolyte film constructions. | Q37978827 | ||
Polymeric multilayer capsules for drug delivery | Q37979152 | ||
TLR7 and TLR9 in SLE: when sensing self goes wrong | Q37995556 | ||
Antigen-specific tolerization approaches in multiple sclerosis. | Q38154948 | ||
Recent progress concerning CpG DNA and its use as a vaccine adjuvant | Q38168903 | ||
Established and novel disease-modifying treatments in multiple sclerosis | Q38180157 | ||
Polymer multilayer tattooing for enhanced DNA vaccination | Q38499608 | ||
Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target. | Q38513283 | ||
Combining antigen and immunomodulators: Emerging trends in antigen-specific immunotherapy for autoimmunity | Q38627493 | ||
Controlled delivery of a metabolic modulator promotes regulatory T cells and restrains autoimmunity | Q39003459 | ||
Expanding antigen-specific regulatory networks to treat autoimmunity | Q40787726 | ||
Rational design of small molecules as vaccine adjuvants. | Q41655108 | ||
Nanoparticle hydrophobicity dictates immune response | Q42095803 | ||
Reversal of autoimmunity by boosting memory-like autoregulatory T cells | Q43104323 | ||
Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis | Q44264011 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunology | Q101929 |
polyelectrolytes | Q901016 | ||
P304 | page(s) | 9334-9345 | |
P577 | publication date | 2016-09-07 | |
P1433 | published in | ACS Nano | Q2819067 |
P1476 | title | Design of Polyelectrolyte Multilayers to Promote Immunological Tolerance | |
P478 | volume | 10 |
Q39271088 | Biomaterial strategies for generating therapeutic immune responses |
Q47846395 | Control of autoimmune inflammation using liposomes to deliver positive allosteric modulators of metabotropic glutamate receptors |
Q53064170 | Designing biomaterials with immunomodulatory properties for tissue engineering and regenerative medicine. |
Q93005872 | Engineering Cell Surfaces with Polyelectrolyte Materials for Translational Applications |
Q52674872 | Engineering Immunological Tolerance Using Quantum Dots to Tune the Density of Self-Antigen Display. |
Q39230209 | Engineering self-assembled materials to study and direct immune function |
Q36225449 | Impact of molecular weight on the intrinsic immunogenic activity of poly(beta amino esters). |
Q47676665 | Improving Vaccine and Immunotherapy Design Using Biomaterials |
Q39245827 | In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance. |
Q48630939 | Modulating the immune system through nanotechnology. |
Q64904747 | Multicomponent peptide assemblies. |
Q48016268 | Polyplexes assembled from self-peptides and regulatory nucleic acids blunt toll-like receptor signaling to combat autoimmunity. |
Q91789130 | Prussian blue nanoparticle-based antigenicity and adjuvanticity trigger robust antitumor immune responses against neuroblastoma |
Q98735466 | Rational Design of Antigen Incorporation Into Subunit Vaccine Biomaterials Can Enhance Antigen-Specific Immune Responses |
Q38695565 | Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling. |
Q48504870 | Targeting Suppressive Oligonucleotide to Lymph Nodes Inhibits Toll-like Receptor-9-Mediated Activation of Adaptive Immunity |
Search more.